GEORGETOWN UNIVERSITY
Patent Owner
Stats
- 214 US PATENTS IN FORCE
- 31 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 214 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,747 Total Citation Count
- Jan 20, 1978 Earliest Filing
- 237 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0053,973 STRIPLINE DETECTOR FOR IN SITU BATTERY AND FUEL CELL NMRAug 21, 17Feb 22, 18[H01M, G01N, G01R]
2017/0351,742 Application Programming Interface and Hypergraph Transfer Protocol Supporting a Global Hypergraph Approach to Reducing Complexity For Accelerated Multi-Disciplinary Scientific DiscoveryJun 05, 17Dec 07, 17[G06N, G06F]
2017/0246,259 Compositions and Methods of Using Interleukin-4 Induced Gene 1 (IL-4I1)Sep 09, 15Aug 31, 17[A61K, C12Q, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9849192 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodiesMar 18, 16Dec 26, 17[A61K, C07K]
9789160 Treatments for lowering glucose levels using FGF binding protein 3Sep 14, 15Oct 17, 17[A61K]
9746985 System and method for detecting, collecting, analyzing, and communicating event-related informationApr 20, 11Aug 29, 17[G06F]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0165,254 TREATING FLAVIVIRUS INFECTIONS WITH AMODIAQUINE AND DERIVATIVES THEREOFAbandonedFeb 05, 15Jun 15, 17[A61K]
2017/0000,746 METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONSAbandonedSep 14, 16Jan 05, 17[A61K]
2015/0311,556 PLATINUM ADLAYERED RUTHENIUM NANOPARTICLES, METHOD FOR PREPARING, AND USES THEREOFAbandonedJul 08, 15Oct 29, 15[H01M]
2015/0252,372 PREPARATION OF ANTIBODY OR AN ANTIBODY FRAGMENT TARGETED IMMUNOLIPOSOMES FOR SYSTEMIC ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC AGENTS AND USES THEREOFAbandonedApr 24, 15Sep 10, 15[A61K, C12N, C07K]
2015/0196,530 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral InfectionsAbandonedJan 26, 15Jul 16, 15[A61K]
2015/0086,648 METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONSAbandonedOct 07, 14Mar 26, 15[A61K]
2014/0341,965 Compositions and Methods Comprising Biodegradable Scaffolds and Retinal Pigment Epithelial CellsAbandonedMar 14, 14Nov 20, 14[A61K, C12N, A61L]
2014/0322,809 Use of a Rock Inhibitor to Sustain Primary Human Keratinocytes in a Proliferative StateAbandonedNov 20, 13Oct 30, 14[C12N]
2014/0294,845 ANTI-PLEIOTROPHIN ANTIBODIES AND METHODS OF USE THEREOFAbandonedFeb 03, 14Oct 02, 14[A61K, C07K]
2014/0287,409 Detection And Assessment Of Cancer Risk Using Telomere HealthAbandonedMar 14, 14Sep 25, 14[C12Q]
2014/0243,319 TREATMENTS TARGETING GAMMA-SYNUCLEIN EXPRESSION LEVELSAbandonedMar 16, 12Aug 28, 14[A61K, G01N]
2014/0178,296 TUMOR-TARGETED NANODELIVERY SYSTEMS TO IMPROVE EARLY MRI DETECTION OF CANCERAbandonedDec 06, 13Jun 26, 14[A61K]
2014/0134,564 ARCH BARS FOR USE IN MAXILLOFACIAL SURGERY AND ORTHODONTICSAbandonedJan 21, 14May 15, 14[A61C]
2014/0121,485 Electrochemical Transdermal Glucose Measurement System Including Microheaters and Process For FormingAbandonedApr 30, 12May 01, 14[C25D, A61B]
2014/0094,384 STROMAL ANTIGEN 2 (STAG2) COMPOSITIONS AND METHODSAbandonedNov 25, 13Apr 03, 14[C12Q, C12N, G01N, C07K]
2014/0066,384 NOVEL GENES AND PROTEINS THAT HOME TO DEVELOPING MICROVESSELSAbandonedApr 15, 13Mar 06, 14[C07K]
2014/0044,873 SINGLE-WALLED CARBON NANOTUBE (SWCNT) FABRICATION BY CONTROLLED CHEMICAL VAPOR DEPOSITION (CVD)AbandonedAug 10, 12Feb 13, 14[C23C, B82Y]
2013/0324,543 REVERSAL OF HIGH BREAST CANCER RISK IN MAMMALS EXPOSED TO ESTROGENIC CHEMICALS IN UTERO BY ADULT EXPOSURE TO HDAC AND DNMT INHIBITORSAbandonedApr 05, 13Dec 05, 13[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.